Additional information
Active substance | Montelukast Sodium |
---|---|
Storage conditions | Store at 20В°C to 25В°C (68В°F to 77В°F) |
Side effects | Headache, abdominal pain, thirst, dizziness, fatigue |
Effects | Decreases bronchoconstriction and inflammation in asthma |
Dosage (sports) | Not applicable |
Dosage (medical) | Typically 10 mg once daily for adults and 4-5 mg for children |
Half-life | 2.7–5.5 hours |
Main action | Reduces inflammation and bronchoconstriction |
Substance class | Leukotriene receptor antagonist |
Formula | C35H36ClNO3S |
Chemical name | 1-(((1R)-1-[(3E)-3-[(1E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanyl)methyl)cyclopropaneacetic acid |
Trade name | Singulair |
Blood pressure | No significant effects on blood pressure |
WAREHOUSE | International Warehouse 2 |
Also known as | Montelukast Sodium |
Lab Test | Not typically required for monitoring |
Aromatization | No |
Hepatotoxicity | No |
HBR | No |
Water Retention | No |
Acne | No |
Classification | Leukotriene-Receptor Antagonist |
Use in sports | Not traditionally used in sports for performance enhancement |
Manufacturer | MSD |
Reviews
There are no reviews yet.